Egr1 has also been shown to lead to upregulation of oxidative stress levels and has been associated with a variety of adverse outcomes, such as myocardial fibrosis, renal fibrosis, pulmonary hypertension, and arrhythmia after myocardial infarction [83–86]. Here, EGR1 is linked to pulmonary hypertension.